| 11231 |
Optical
coherence tomography and vessel diameter changes after intravitreal bevacizumab in
diabetic macular oedema |
Department of Ophthalmology |
2008 |
| 11232 |
Optical coherence tomography imaging of bullous diseases |
Department of Dermatology |
2008 |
| 11233 |
Opt[cal coherence tomography and vessel diameter changes after intra vitreal bevacizumab in diabetic macular edema |
Department of Ophthalmology |
2008 |
| 11234 |
Opt[cal coherence tomography and vessel diameter changes after intra vitreal bevacizumab in diabetic macular edema |
Department of Ophthalmology |
2008 |
| 11235 |
OUTCOME OF SAUDI AND EGYPTIAN PATIENTS RECEIVING CADAVERIC LIVER TRANSPLANTATION IN CHINA |
Department of Gastroenterology and Tropical Medicine |
2008 |
| 11236 |
Oxidative Modification of Low-Density Lipoprotein in Relation to Dyslipidemia and Oxidant Status in Children with Steroid Sensitive Nephrotic Syndrome. |
Department of Biochemistry |
2008 |
| 11237 |
Oxidative Modification of Low-Density Lipoprotein in Relation to Dyslipidemia and Oxidant Status in Children with Steroid Sensitive Nephrotic Syndrome. |
Department of Pediatrics |
2008 |
| 11238 |
Oxidative Modification of Low-Density Lipoprotein in Relation to Dyslipidemia and Oxidant Status in Children with Steroid Sensitive Nephrotic Syndrome. |
Department of Pediatrics |
2008 |
| 11239 |
Pegylated polybutylcyanoacrylate nanoparticles as a vector for enhancement of baclofen delivery through blood-brain barrier. |
Department of Pharmacology |
2008 |
| 11240 |
Pharmacokineetics of Oral tramadol in patients with liver cancer . |
Department of Anesthesia and Intensive Care |
2008 |